After Sarepta reported the death of a patient who had recently taken the gene therapy Elevidys, patient advocacy group Parent ...
1d
Clinical Trials Arena on MSNRegenxbio’s DMD gene therapy drives 122.3% biomarker uptick in three-year-oldThe interim data found one child in the Duchenne trial produced more than double the amount of the protein needed to maintain ...
A young person with Duchenne muscular dystrophy died following treatment with the recently approved gene therapy ...
A patient has died while taking a closely watched gene therapy for muscular dystrophy. Sarepta Therapeutics announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results